酶解蛋白饲料原料开发
Search documents
美农生物(301156) - 上海美农生物科技股份有限公司投资者关系活动记录表20250919
2025-09-19 09:56
Group 1: Financial Performance - The company achieved a revenue of 236 million CNY in the first half of 2025, representing a year-on-year growth of 13.69% [2] - The net profit attributable to shareholders reached 23.53 million CNY, with a year-on-year increase of 17.68% [5] - The net profit after deducting non-recurring gains and losses was 21.84 million CNY, showing a growth of 27.46% year-on-year [5] Group 2: Market Strategy - The company adheres to a market strategy of "deepening domestic and breaking into international markets" and a product strategy of "differentiated species and full nutrition" [3] - In the domestic market, the focus is on core customer development, particularly in the pig, dairy cow, and poultry sectors, while also expanding into aquaculture and beef markets [5] - Internationally, the company has increased efforts in market development, achieving rapid revenue growth in over ten countries including Vietnam, Russia, and Brazil [3] Group 3: Product Development - The company emphasizes innovation in feed additives and enzyme hydrolyzed protein raw materials, with a commitment to developing efficient, safe, and environmentally friendly products [4] - Two new patents were added in the first half of the year, and the company plans to enhance its R&D capabilities to continuously improve technological innovation [6] - A new corn protein processing project is expected to be completed and enter trial production this year, which will help alleviate the domestic protein resource shortage [4] Group 4: Risk Management - The company has established long-term partnerships with upstream suppliers to mitigate the impact of raw material price fluctuations, including locking in prices through long-term contracts [7] - The company has a diversified supply chain and conducts real-time market analysis to manage costs effectively [7] - The strategy includes expanding product applications across various fields such as ruminants, poultry, aquaculture, and pets to reduce risks associated with product category concentration [4]